Elbute 800 Tablet contains Ethambutol 800mg, a high-dose anti-tuberculosis medicine used in combination therapy for managing active TB infections. It effectively inhibits the growth of Mycobacterium tuberculosis, supporting treatment of pulmonary and extrapulmonary tuberculosis.
The 800mg strength is suitable for adult patients requiring intensive therapy or inclusion in multi-drug regimens to prevent resistance and ensure effective bacterial control. Its high potency makes it essential in clinical TB treatment protocols.
For hospitals, TB clinics, and distributors, Elbute 800 Tablet is a consistently demanded anti-TB product, stocked in outpatient TB departments, public health programs, and specialty respiratory care units. Regular usage ensures sustained orders and market demand.
Adding Elbute 800 Tablet to your portfolio strengthens your respiratory and infectious disease segment, opening opportunities in hospital supply chains, pharmacy distribution, institutional tenders, export markets, and third-party manufacturing. Its critical role in TB treatment makes it a valuable and high-importance product for pharmaceutical distributors.